The Haute Autorité de Santé issued updated clinical guidelines on July 16, 2026, overhauling how dental professionals prescribe antibiotics to combat rising antimicrobial resistance. According to the agency, the new framework replaces outdated 2011 standards set by the Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) and targets heterogeneous prescribing habits across oral healthcare.
Clinical Objectives and Scope of the 2026 Guidelines
According to the Haute Autorité de Santé, the updated guidelines form part of the national strategy for infection prevention and antimicrobial resistance spanning 2022 to 2025. Overuse and misuse of antimicrobial drugs have accelerated bacterial resistance, leading to more difficult hospitalizations and increased mortality risks during surgical procedures. The 2026 framework applies to all adult and pediatric patients in general populations or risk categories, guiding practitioners including general dentists, oral surgeons, maxillofacial surgeons, general practitioners, pediatricians, and hospital specialists managing odontogenic infections.
First-Line Treatments and Dosage Standards
Amoxicillin remains the first-line antibiotic of choice for dental indications, according to the Haute Autorité de Santé. For antibiotic prophylaxis in adults, the standard dosage is 2 grams administered one hour before the dental procedure, with a window of up to two hours after in case of emergency or omission. For curative antibiotic therapy, the recommended dosage is 1 gram taken three times per day for a duration of three days. The agency emphasizes that treatment duration should be kept short, as studies show short-course treatments yield clinical outcomes comparable to prolonged regimens for many infections.
Restrictions on Local Treatments and Combination Therapy
Local antibiotic therapy is now explicitly discouraged in routine oral and dental practice, according to the Haute Autorité de Santé. Furthermore, dual antibiotic therapy (bitherapy) is reserved strictly for complex clinical situations such as osteitis, osteomyelitis, acute maxillary sinusitis of dental origin, superinfected osteonecrosis of the jaws, severe periodontitis, or heavily contaminated wounds. The agency also notes that systematically pairing an anti-inflammatory drug with an antibiotic provides no demonstrated clinical benefit.
Integration with Local Etiological Care
Dental pain is predominantly inflammatory and requires immediate mechanical or etiological treatment rather than automatic medication, according to the Haute Autorité de Santé. Clinicians must pair any necessary antibiotic therapy with local interventions designed to drain infections or address root causes, such as surgical incisions, debridement, scaling, root planing, pulpectomy, or tooth extraction. Antibiotic prophylaxis itself is restricted strictly to interventions carrying a significant, proven infection risk.
Related reading